ExeGi Pharma gets clearance of IND application for EXE-346 a Live biotherapeutic biologic drug
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
mRNA-1345 demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or more symptoms in older adults
Multilateral collaborations will serve to strengthen knowledge sharing to formulate framework for accessible, affordable, and quality healthcare
India is working towards augmenting health infrastructure and have initiated multiple schemes to strengthen health systems and improve health service delivery
AI-based medical imaging equipment firm Lunit has signed a contract to supply AI-based breast cancer screening solution “Lunit Insight MMG”
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
Under the soon to be launched Heal in India initiative, India aims to provide its health infrastructure for patients abroad and make it a global hub for medical and value-based healthcare for patients from across the world
Subscribe To Our Newsletter & Stay Updated